Authors: Bush, MA Samara, E Whitehouse, MJ Yoshizawa, C Novicki, DL Pike, M Laham, RJ Simons, M Chronos, NA

Citation: Ma. Bush et al., Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease, J CLIN PHAR, 41(4), 2001, pp. 378-385

Authors: Karwatowski, SP Chronos, NA Sinclaire, H Forbat, SM Sutton, MGS Black, C Underwood, SR Pennell, DJ

Citation: Sp. Karwatowski et al., Effect of systemic sclerosis on left ventricular long-axis motion and leftventricular mass assessed by magnetic resonance, J CARD M RE, 2(2), 2000, pp. 109-117

Authors: Laham, RJ Chronos, NA Pike, M Leimbach, ME Udelson, JE Pearlman, JD Pettigrew, RI Whitehouse, MJ Yoshizawa, C Simons, M

Citation: Rj. Laham et al., Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study, J AM COL C, 36(7), 2000, pp. 2132-2139

Authors: Simons, M Bonow, RO Chronos, NA Cohen, DJ Giordano, FJ Hammond, HK Laham, RJ Li, W Pike, M Sellke, FW Stegmann, TJ Udelson, JE Rosengart, TK

Citation: M. Simons et al., Clinical trials in coronary angiogenesis: Issues, problems, consensus - Anexpert panel summary, CIRCULATION, 102(11), 2000, pp. E73-E86

Authors: Salame, MY King, SB Chronos, NA

Citation: My. Salame et al., Tirofiban in coronary intervention - The RESTORE trial, CONTEMP CAR, 2, 1999, pp. 127-142